Semaglutide shortage sparks patient demands for alternatives But in Australia, the new drug generating the most interest is still in its infancy – and not yet listed on the PBS.
Virtual care piloted for pregnant women A new program has launched to urgently connect those with symptoms of pregnancy loss to a midwife, but GPs say they need to be kept in the loop.
Do not initiate new patients on semaglutide: TGA The medication is again in short supply due to off-label prescribing for weight loss, despite only being approved for type 2 diabetes management.
GPs ‘underutilised’ for hepatitis B care Australia’s treatment targets are lagging behind, but GPs can help by playing a larger part in managing care, referral pathways and prescribing.
How should GPs discuss weight with their patients? A high-profile body image advocate wants doctors to stop raising the issue, but clinicians say there are ways to sensitively approach the topic.
Specialist colleges in united front against pharmacy prescribing Allowing pharmacists to prescribe Schedule 4 medications has been described as ‘inconsistent with good practice’.
Controversial pharmacy income deal under assessment An agreement that guarantees pharmacies’ income for prescriptions is being reviewed for its ‘fitness for purpose’.
Debate over ‘doctor-approved’ weight loss drugs obtained online Is a GP-reviewed online questionnaire clinically sufficient to safely prescribe injectable medications without a face-to-face consultation? It depends who you ask.
TGA warns of online semaglutide scams The medicines regulator has said scams include advertising offers being sent to GPs for distribution to patients.
Study links frailty risk with obesity Routine assessment of BMI is a fundamental part of reducing the risk of frailty in older age, according to both new research and a local expert.